Doctor'S Formulas Bromeact Anti-Inflammatory Formula 30Mg 30 Caps The Natural Composition Of Bromeact Ensures A Potent Anti-Inflammatory Action, As Well As A Decrease In The Swelling That Is Caused By Inflammation. Active Ingredients: Bromelain: Increases The Production Of Prostaglandins With Anti-Inflammatory Action. Inhibits The Transformation Of Kininogen Into Kinin. Stimulates Pge1 (Selectively Inhibits The Accumulation Of Platelets And Consequently Blood Coagulation). Develops A Fibrinolytic Action In Interaction With The Lipoxygenase Through The Plasminogen (Increases Plasmin Creation), Which Breaks Down The Fibrin Clots (Fibrinolysis), Delaying At The Same Time The Creation Of A Local Swelling. Boswellic Acid: Selectively Inhibits 5-Lipoxygenase, And Blocks The Synthesis Of Leukotrienes B4 (Receptor Of Chronic Inflammation Phase) Along With The Leukotrienes C4, D4, E4 (Receptors Of Acute Inflammation Phase). Does Not Reverse The Synthesis Of Gastroprotective Prostaglandins As It Happens With The Nsaids [Non Steroidal Anti-Inflammatory Drugs]. Reverses The Shift Of The Polymorphonuclear Leukocytes And The Release Of Proteolytic Enzynes. Cumarin: Acts In The Lymphatic System Due To Its Ability To Increase The Proteolytic Action Of Macrophages. Decreases The Catabolism Of Catecholamines (Adrenalin) On A Vascular Level And Contributes To The Ability Of Capillaries To Contract; As A Result It Reduces Swelling And Pain. Warnings: This Product Is Not Intended For Prevention, Treatment Or Cure Of The Human Disease. Consult Your Doctor If You Are Pregnant Of Breastfeeding, If You Are Under Pharmaceutical Treatment Or Face Health Problems. Notification Number Of The European Medicines Agency (Emea): 28343/8-4-2013. The Notification Number In The European Medicines Agency (Emea) Does Not Serve As A Distribution Permit From The European Medicines Agency (Emea).